For instance, in non-alcoholic fatty liver disease (NAFLD), activating SIRT1 can enhance the transcriptional regulation of genes involved in mitochondrial biogenesis, maintaining energy and metabolic stability. This evidence concerns the gene SIRT1 and metabolic dysfunction-associated steatotic liver disease.